128940.KS in “GLP-1 Eats Everything”
Hanmi Pharm. Co., Ltd.
Hanmi has a differentiated obesity pipeline led by long-acting multi-agonist candidates targeting GLP-1, GIP and glucagon pathways.
128940.KS impact map — “GLP-1 Eats Everything”
How this story travels from the headline to 128940.KS’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading 128940.KS impact map…
Price history, marked with story events
Aug 25, 2025 – Aug 25, 2026 · 243 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BULL side — Hanmi has a differentiated obesity pipeline led by long-acting multi-agonist candidates targeting GLP-1, GIP and glucagon pathways.
Read the full GLP-1 Eats Everything story